1. Home
  2. NUWE vs ELAB Comparison

NUWE vs ELAB Comparison

Compare NUWE & ELAB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • NUWE
  • ELAB
  • Stock Information
  • Founded
  • NUWE 1999
  • ELAB 2020
  • Country
  • NUWE United States
  • ELAB United States
  • Employees
  • NUWE N/A
  • ELAB N/A
  • Industry
  • NUWE Biotechnology: Electromedical & Electrotherapeutic Apparatus
  • ELAB
  • Sector
  • NUWE Health Care
  • ELAB
  • Exchange
  • NUWE Nasdaq
  • ELAB Nasdaq
  • Market Cap
  • NUWE 3.9M
  • ELAB 3.2M
  • IPO Year
  • NUWE N/A
  • ELAB 2023
  • Fundamental
  • Price
  • NUWE $6.88
  • ELAB $2.23
  • Analyst Decision
  • NUWE Strong Buy
  • ELAB
  • Analyst Count
  • NUWE 1
  • ELAB 0
  • Target Price
  • NUWE $714.00
  • ELAB N/A
  • AVG Volume (30 Days)
  • NUWE 121.9K
  • ELAB 157.3K
  • Earning Date
  • NUWE 08-12-2025
  • ELAB 08-13-2025
  • Dividend Yield
  • NUWE N/A
  • ELAB N/A
  • EPS Growth
  • NUWE N/A
  • ELAB N/A
  • EPS
  • NUWE N/A
  • ELAB N/A
  • Revenue
  • NUWE $8,787,000.00
  • ELAB N/A
  • Revenue This Year
  • NUWE $6.53
  • ELAB N/A
  • Revenue Next Year
  • NUWE $51.63
  • ELAB N/A
  • P/E Ratio
  • NUWE N/A
  • ELAB N/A
  • Revenue Growth
  • NUWE N/A
  • ELAB N/A
  • 52 Week Low
  • NUWE $6.73
  • ELAB $1.95
  • 52 Week High
  • NUWE $197.40
  • ELAB $791.00
  • Technical
  • Relative Strength Index (RSI)
  • NUWE 25.34
  • ELAB 50.30
  • Support Level
  • NUWE $7.20
  • ELAB $2.18
  • Resistance Level
  • NUWE $10.08
  • ELAB $2.40
  • Average True Range (ATR)
  • NUWE 0.99
  • ELAB 0.14
  • MACD
  • NUWE 0.64
  • ELAB 0.04
  • Stochastic Oscillator
  • NUWE 10.66
  • ELAB 53.66

About NUWE Nuwellis Inc.

Nuwellis Inc is a medical technology company focused on developing, manufacturing, and commercializing a medical device used in ultrafiltration therapy, including the Aquadex FlexFlow and the Aquadex SmartFlow systems. The Aquadex Smartflow System removes excess fluid from patients suffering from fluid overload who have not responded to medical management, including diuretics. Nuwellis has one reportable segment: fluid overload.

About ELAB Elevai Labs Inc.

PMGC Holdings Inc advancing in Medical Aesthetics and Biopharmaceutical Innovation. It specializes in Skin Aesthetics, Obesity, and Metabolic Health business.

Share on Social Networks: